Medtronic Banking On S670 Stent, Pipeline For Vascular Business Rebound
This article was originally published in The Gray Sheet
Executive Summary
U.S. feasibility trials of Medtronic's INX neurovascular stent for the treatment of atherosclerotic vessels in the brain began Aug. 11, the company announced Aug. 23.